cohortId,targetId,targetName,strataId,strataName,cohortType
101,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,0,All,Target
102,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,0,All,Target
103,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,0,All,Target
104,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,0,All,Target
105,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,0,All,Target
106,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,0,All,Target
107,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,0,All,Target
108,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,0,All,Target
109,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,0,All,Target
110,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,0,All,Target
111,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,0,All,Target
112,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,0,All,Target
113,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,0,All,Target
114,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,0,All,Target
115,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,0,All,Target
116,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,0,All,Target
117,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,0,All,Target
118,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,0,All,Target
101002832,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,283,without Performance Status ECOG=0,TwoS
102002832,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,283,without Performance Status ECOG=0,TwoS
103002832,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,283,without Performance Status ECOG=0,TwoS
104002832,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,283,without Performance Status ECOG=0,TwoS
105002832,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,283,without Performance Status ECOG=0,TwoS
106002832,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,283,without Performance Status ECOG=0,TwoS
107002832,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,283,without Performance Status ECOG=0,TwoS
108002832,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,283,without Performance Status ECOG=0,TwoS
109002832,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,283,without Performance Status ECOG=0,TwoS
110002832,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,283,without Performance Status ECOG=0,TwoS
111002832,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,283,without Performance Status ECOG=0,TwoS
112002832,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,283,without Performance Status ECOG=0,TwoS
113002832,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,283,without Performance Status ECOG=0,TwoS
114002832,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,283,without Performance Status ECOG=0,TwoS
115002832,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,283,without Performance Status ECOG=0,TwoS
116002832,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,283,without Performance Status ECOG=0,TwoS
117002832,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,283,without Performance Status ECOG=0,TwoS
118002832,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,283,without Performance Status ECOG=0,TwoS
101002842,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,284,without Hypertension,TwoS
102002842,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,284,without Hypertension,TwoS
103002842,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,284,without Hypertension,TwoS
104002842,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,284,without Hypertension,TwoS
105002842,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,284,without Hypertension,TwoS
106002842,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,284,without Hypertension,TwoS
107002842,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,284,without Hypertension,TwoS
108002842,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,284,without Hypertension,TwoS
109002842,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,284,without Hypertension,TwoS
110002842,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,284,without Hypertension,TwoS
111002842,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,284,without Hypertension,TwoS
112002842,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,284,without Hypertension,TwoS
113002842,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,284,without Hypertension,TwoS
114002842,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,284,without Hypertension,TwoS
115002842,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,284,without Hypertension,TwoS
116002842,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,284,without Hypertension,TwoS
117002842,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,284,without Hypertension,TwoS
118002842,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,284,without Hypertension,TwoS
101002862,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,286,without Cardiovascular Disease Event,TwoS
102002862,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,286,without Cardiovascular Disease Event,TwoS
103002862,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,286,without Cardiovascular Disease Event,TwoS
104002862,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,286,without Cardiovascular Disease Event,TwoS
105002862,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,286,without Cardiovascular Disease Event,TwoS
106002862,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,286,without Cardiovascular Disease Event,TwoS
107002862,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,286,without Cardiovascular Disease Event,TwoS
108002862,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,286,without Cardiovascular Disease Event,TwoS
109002862,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,286,without Cardiovascular Disease Event,TwoS
110002862,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,286,without Cardiovascular Disease Event,TwoS
111002862,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,286,without Cardiovascular Disease Event,TwoS
112002862,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,286,without Cardiovascular Disease Event,TwoS
113002862,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,286,without Cardiovascular Disease Event,TwoS
114002862,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,286,without Cardiovascular Disease Event,TwoS
115002862,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,286,without Cardiovascular Disease Event,TwoS
116002862,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,286,without Cardiovascular Disease Event,TwoS
117002862,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,286,without Cardiovascular Disease Event,TwoS
118002862,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,286,without Cardiovascular Disease Event,TwoS
101002872,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,287,without Diabetes 2,TwoS
102002872,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,287,without Diabetes 2,TwoS
103002872,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,287,without Diabetes 2,TwoS
104002872,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,287,without Diabetes 2,TwoS
105002872,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,287,without Diabetes 2,TwoS
106002872,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,287,without Diabetes 2,TwoS
107002872,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,287,without Diabetes 2,TwoS
108002872,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,287,without Diabetes 2,TwoS
109002872,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,287,without Diabetes 2,TwoS
110002872,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,287,without Diabetes 2,TwoS
111002872,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,287,without Diabetes 2,TwoS
112002872,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,287,without Diabetes 2,TwoS
113002872,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,287,without Diabetes 2,TwoS
114002872,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,287,without Diabetes 2,TwoS
115002872,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,287,without Diabetes 2,TwoS
116002872,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,287,without Diabetes 2,TwoS
117002872,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,287,without Diabetes 2,TwoS
118002872,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,287,without Diabetes 2,TwoS
101002882,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,288,without Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwoS
102002882,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,288,without Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwoS
103002882,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,288,without Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwoS
104002882,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,288,without Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwoS
105002882,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,288,without Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwoS
106002882,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,288,without Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwoS
107002882,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,288,without Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwoS
108002882,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,288,without Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwoS
109002882,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,288,without Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwoS
110002882,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,288,without Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwoS
111002882,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,288,without Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwoS
112002882,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,288,without Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwoS
113002882,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,288,without Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwoS
114002882,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,288,without Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwoS
115002882,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,288,without Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwoS
116002882,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,288,without Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwoS
117002882,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,288,without Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwoS
118002882,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,288,without Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwoS
101002892,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,289,without Anxiety,TwoS
102002892,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,289,without Anxiety,TwoS
103002892,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,289,without Anxiety,TwoS
104002892,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,289,without Anxiety,TwoS
105002892,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,289,without Anxiety,TwoS
106002892,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,289,without Anxiety,TwoS
107002892,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,289,without Anxiety,TwoS
108002892,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,289,without Anxiety,TwoS
109002892,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,289,without Anxiety,TwoS
110002892,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,289,without Anxiety,TwoS
111002892,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,289,without Anxiety,TwoS
112002892,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,289,without Anxiety,TwoS
113002892,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,289,without Anxiety,TwoS
114002892,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,289,without Anxiety,TwoS
115002892,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,289,without Anxiety,TwoS
116002892,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,289,without Anxiety,TwoS
117002892,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,289,without Anxiety,TwoS
118002892,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,289,without Anxiety,TwoS
101003102,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,310,without Fatique or malaise,TwoS
102003102,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,310,without Fatique or malaise,TwoS
103003102,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,310,without Fatique or malaise,TwoS
104003102,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,310,without Fatique or malaise,TwoS
105003102,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,310,without Fatique or malaise,TwoS
106003102,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,310,without Fatique or malaise,TwoS
107003102,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,310,without Fatique or malaise,TwoS
108003102,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,310,without Fatique or malaise,TwoS
109003102,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,310,without Fatique or malaise,TwoS
110003102,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,310,without Fatique or malaise,TwoS
111003102,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,310,without Fatique or malaise,TwoS
112003102,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,310,without Fatique or malaise,TwoS
113003102,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,310,without Fatique or malaise,TwoS
114003102,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,310,without Fatique or malaise,TwoS
115003102,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,310,without Fatique or malaise,TwoS
116003102,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,310,without Fatique or malaise,TwoS
117003102,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,310,without Fatique or malaise,TwoS
118003102,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,310,without Fatique or malaise,TwoS
101004032,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,403,without Osteopenia and Osteoporosis,TwoS
102004032,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,403,without Osteopenia and Osteoporosis,TwoS
103004032,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,403,without Osteopenia and Osteoporosis,TwoS
104004032,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,403,without Osteopenia and Osteoporosis,TwoS
105004032,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,403,without Osteopenia and Osteoporosis,TwoS
106004032,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,403,without Osteopenia and Osteoporosis,TwoS
107004032,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,403,without Osteopenia and Osteoporosis,TwoS
108004032,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,403,without Osteopenia and Osteoporosis,TwoS
109004032,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,403,without Osteopenia and Osteoporosis,TwoS
110004032,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,403,without Osteopenia and Osteoporosis,TwoS
111004032,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,403,without Osteopenia and Osteoporosis,TwoS
112004032,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,403,without Osteopenia and Osteoporosis,TwoS
113004032,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,403,without Osteopenia and Osteoporosis,TwoS
114004032,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,403,without Osteopenia and Osteoporosis,TwoS
115004032,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,403,without Osteopenia and Osteoporosis,TwoS
116004032,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,403,without Osteopenia and Osteoporosis,TwoS
117004032,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,403,without Osteopenia and Osteoporosis,TwoS
118004032,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,403,without Osteopenia and Osteoporosis,TwoS
101004072,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,407,without Anemia,TwoS
102004072,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,407,without Anemia,TwoS
103004072,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,407,without Anemia,TwoS
104004072,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,407,without Anemia,TwoS
105004072,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,407,without Anemia,TwoS
106004072,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,407,without Anemia,TwoS
107004072,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,407,without Anemia,TwoS
108004072,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,407,without Anemia,TwoS
109004072,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,407,without Anemia,TwoS
110004072,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,407,without Anemia,TwoS
111004072,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,407,without Anemia,TwoS
112004072,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,407,without Anemia,TwoS
113004072,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,407,without Anemia,TwoS
114004072,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,407,without Anemia,TwoS
115004072,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,407,without Anemia,TwoS
116004072,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,407,without Anemia,TwoS
117004072,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,407,without Anemia,TwoS
118004072,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,407,without Anemia,TwoS
101004222,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,422,without Performance Status ECOG=1,TwoS
102004222,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,422,without Performance Status ECOG=1,TwoS
103004222,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,422,without Performance Status ECOG=1,TwoS
104004222,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,422,without Performance Status ECOG=1,TwoS
105004222,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,422,without Performance Status ECOG=1,TwoS
106004222,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,422,without Performance Status ECOG=1,TwoS
107004222,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,422,without Performance Status ECOG=1,TwoS
108004222,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,422,without Performance Status ECOG=1,TwoS
109004222,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,422,without Performance Status ECOG=1,TwoS
110004222,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,422,without Performance Status ECOG=1,TwoS
111004222,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,422,without Performance Status ECOG=1,TwoS
112004222,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,422,without Performance Status ECOG=1,TwoS
113004222,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,422,without Performance Status ECOG=1,TwoS
114004222,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,422,without Performance Status ECOG=1,TwoS
115004222,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,422,without Performance Status ECOG=1,TwoS
116004222,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,422,without Performance Status ECOG=1,TwoS
117004222,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,422,without Performance Status ECOG=1,TwoS
118004222,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,422,without Performance Status ECOG=1,TwoS
101007972,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,797,without Hepatotoxicity/Liver failure,TwoS
102007972,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,797,without Hepatotoxicity/Liver failure,TwoS
103007972,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,797,without Hepatotoxicity/Liver failure,TwoS
104007972,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,797,without Hepatotoxicity/Liver failure,TwoS
105007972,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,797,without Hepatotoxicity/Liver failure,TwoS
106007972,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,797,without Hepatotoxicity/Liver failure,TwoS
107007972,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,797,without Hepatotoxicity/Liver failure,TwoS
108007972,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,797,without Hepatotoxicity/Liver failure,TwoS
109007972,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,797,without Hepatotoxicity/Liver failure,TwoS
110007972,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,797,without Hepatotoxicity/Liver failure,TwoS
111007972,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,797,without Hepatotoxicity/Liver failure,TwoS
112007972,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,797,without Hepatotoxicity/Liver failure,TwoS
113007972,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,797,without Hepatotoxicity/Liver failure,TwoS
114007972,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,797,without Hepatotoxicity/Liver failure,TwoS
115007972,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,797,without Hepatotoxicity/Liver failure,TwoS
116007972,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,797,without Hepatotoxicity/Liver failure,TwoS
117007972,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,797,without Hepatotoxicity/Liver failure,TwoS
118007972,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,797,without Hepatotoxicity/Liver failure,TwoS
101008082,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,808,without Dementia,TwoS
102008082,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,808,without Dementia,TwoS
103008082,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,808,without Dementia,TwoS
104008082,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,808,without Dementia,TwoS
105008082,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,808,without Dementia,TwoS
106008082,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,808,without Dementia,TwoS
107008082,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,808,without Dementia,TwoS
108008082,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,808,without Dementia,TwoS
109008082,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,808,without Dementia,TwoS
110008082,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,808,without Dementia,TwoS
111008082,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,808,without Dementia,TwoS
112008082,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,808,without Dementia,TwoS
113008082,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,808,without Dementia,TwoS
114008082,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,808,without Dementia,TwoS
115008082,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,808,without Dementia,TwoS
116008082,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,808,without Dementia,TwoS
117008082,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,808,without Dementia,TwoS
118008082,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,808,without Dementia,TwoS
101008102,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,810,without Memory impairment,TwoS
102008102,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,810,without Memory impairment,TwoS
103008102,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,810,without Memory impairment,TwoS
104008102,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,810,without Memory impairment,TwoS
105008102,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,810,without Memory impairment,TwoS
106008102,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,810,without Memory impairment,TwoS
107008102,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,810,without Memory impairment,TwoS
108008102,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,810,without Memory impairment,TwoS
109008102,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,810,without Memory impairment,TwoS
110008102,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,810,without Memory impairment,TwoS
111008102,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,810,without Memory impairment,TwoS
112008102,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,810,without Memory impairment,TwoS
113008102,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,810,without Memory impairment,TwoS
114008102,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,810,without Memory impairment,TwoS
115008102,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,810,without Memory impairment,TwoS
116008102,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,810,without Memory impairment,TwoS
117008102,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,810,without Memory impairment,TwoS
118008102,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,810,without Memory impairment,TwoS
101008422,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,842,without Depression,TwoS
102008422,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,842,without Depression,TwoS
103008422,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,842,without Depression,TwoS
104008422,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,842,without Depression,TwoS
105008422,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,842,without Depression,TwoS
106008422,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,842,without Depression,TwoS
107008422,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,842,without Depression,TwoS
108008422,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,842,without Depression,TwoS
109008422,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,842,without Depression,TwoS
110008422,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,842,without Depression,TwoS
111008422,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,842,without Depression,TwoS
112008422,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,842,without Depression,TwoS
113008422,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,842,without Depression,TwoS
114008422,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,842,without Depression,TwoS
115008422,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,842,without Depression,TwoS
116008422,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,842,without Depression,TwoS
117008422,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,842,without Depression,TwoS
118008422,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,842,without Depression,TwoS
101008512,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,851,without Respiratory distress,TwoS
102008512,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,851,without Respiratory distress,TwoS
103008512,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,851,without Respiratory distress,TwoS
104008512,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,851,without Respiratory distress,TwoS
105008512,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,851,without Respiratory distress,TwoS
106008512,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,851,without Respiratory distress,TwoS
107008512,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,851,without Respiratory distress,TwoS
108008512,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,851,without Respiratory distress,TwoS
109008512,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,851,without Respiratory distress,TwoS
110008512,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,851,without Respiratory distress,TwoS
111008512,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,851,without Respiratory distress,TwoS
112008512,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,851,without Respiratory distress,TwoS
113008512,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,851,without Respiratory distress,TwoS
114008512,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,851,without Respiratory distress,TwoS
115008512,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,851,without Respiratory distress,TwoS
116008512,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,851,without Respiratory distress,TwoS
117008512,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,851,without Respiratory distress,TwoS
118008512,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,851,without Respiratory distress,TwoS
101008892,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,889,without Kidney failure,TwoS
102008892,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,889,without Kidney failure,TwoS
103008892,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,889,without Kidney failure,TwoS
104008892,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,889,without Kidney failure,TwoS
105008892,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,889,without Kidney failure,TwoS
106008892,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,889,without Kidney failure,TwoS
107008892,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,889,without Kidney failure,TwoS
108008892,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,889,without Kidney failure,TwoS
109008892,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,889,without Kidney failure,TwoS
110008892,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,889,without Kidney failure,TwoS
111008892,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,889,without Kidney failure,TwoS
112008892,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,889,without Kidney failure,TwoS
113008892,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,889,without Kidney failure,TwoS
114008892,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,889,without Kidney failure,TwoS
115008892,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,889,without Kidney failure,TwoS
116008892,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,889,without Kidney failure,TwoS
117008892,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,889,without Kidney failure,TwoS
118008892,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,889,without Kidney failure,TwoS
101009842,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,984,without BMI above 30,TwoS
102009842,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,984,without BMI above 30,TwoS
103009842,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,984,without BMI above 30,TwoS
104009842,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,984,without BMI above 30,TwoS
105009842,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,984,without BMI above 30,TwoS
106009842,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,984,without BMI above 30,TwoS
107009842,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,984,without BMI above 30,TwoS
108009842,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,984,without BMI above 30,TwoS
109009842,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,984,without BMI above 30,TwoS
110009842,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,984,without BMI above 30,TwoS
111009842,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,984,without BMI above 30,TwoS
112009842,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,984,without BMI above 30,TwoS
113009842,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,984,without BMI above 30,TwoS
114009842,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,984,without BMI above 30,TwoS
115009842,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,984,without BMI above 30,TwoS
116009842,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,984,without BMI above 30,TwoS
117009842,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,984,without BMI above 30,TwoS
118009842,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,984,without BMI above 30,TwoS
101009852,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,985,without Charlson Comorbidity Index (cut off 0),TwoS
102009852,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,985,without Charlson Comorbidity Index (cut off 0),TwoS
103009852,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,985,without Charlson Comorbidity Index (cut off 0),TwoS
104009852,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,985,without Charlson Comorbidity Index (cut off 0),TwoS
105009852,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,985,without Charlson Comorbidity Index (cut off 0),TwoS
106009852,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,985,without Charlson Comorbidity Index (cut off 0),TwoS
107009852,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,985,without Charlson Comorbidity Index (cut off 0),TwoS
108009852,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,985,without Charlson Comorbidity Index (cut off 0),TwoS
109009852,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,985,without Charlson Comorbidity Index (cut off 0),TwoS
110009852,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,985,without Charlson Comorbidity Index (cut off 0),TwoS
111009852,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,985,without Charlson Comorbidity Index (cut off 0),TwoS
112009852,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,985,without Charlson Comorbidity Index (cut off 0),TwoS
113009852,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,985,without Charlson Comorbidity Index (cut off 0),TwoS
114009852,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,985,without Charlson Comorbidity Index (cut off 0),TwoS
115009852,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,985,without Charlson Comorbidity Index (cut off 0),TwoS
116009852,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,985,without Charlson Comorbidity Index (cut off 0),TwoS
117009852,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,985,without Charlson Comorbidity Index (cut off 0),TwoS
118009852,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,985,without Charlson Comorbidity Index (cut off 0),TwoS
101009862,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,986,without Charlson Comorbidity Index (cut off 1),TwoS
102009862,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,986,without Charlson Comorbidity Index (cut off 1),TwoS
103009862,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,986,without Charlson Comorbidity Index (cut off 1),TwoS
104009862,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,986,without Charlson Comorbidity Index (cut off 1),TwoS
105009862,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,986,without Charlson Comorbidity Index (cut off 1),TwoS
106009862,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,986,without Charlson Comorbidity Index (cut off 1),TwoS
107009862,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,986,without Charlson Comorbidity Index (cut off 1),TwoS
108009862,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,986,without Charlson Comorbidity Index (cut off 1),TwoS
109009862,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,986,without Charlson Comorbidity Index (cut off 1),TwoS
110009862,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,986,without Charlson Comorbidity Index (cut off 1),TwoS
111009862,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,986,without Charlson Comorbidity Index (cut off 1),TwoS
112009862,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,986,without Charlson Comorbidity Index (cut off 1),TwoS
113009862,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,986,without Charlson Comorbidity Index (cut off 1),TwoS
114009862,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,986,without Charlson Comorbidity Index (cut off 1),TwoS
115009862,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,986,without Charlson Comorbidity Index (cut off 1),TwoS
116009862,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,986,without Charlson Comorbidity Index (cut off 1),TwoS
117009862,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,986,without Charlson Comorbidity Index (cut off 1),TwoS
118009862,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,986,without Charlson Comorbidity Index (cut off 1),TwoS
101009872,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,987,without Charlson Comorbidity Index (cut off >=2),TwoS
102009872,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,987,without Charlson Comorbidity Index (cut off >=2),TwoS
103009872,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,987,without Charlson Comorbidity Index (cut off >=2),TwoS
104009872,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,987,without Charlson Comorbidity Index (cut off >=2),TwoS
105009872,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,987,without Charlson Comorbidity Index (cut off >=2),TwoS
106009872,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,987,without Charlson Comorbidity Index (cut off >=2),TwoS
107009872,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,987,without Charlson Comorbidity Index (cut off >=2),TwoS
108009872,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,987,without Charlson Comorbidity Index (cut off >=2),TwoS
109009872,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,987,without Charlson Comorbidity Index (cut off >=2),TwoS
110009872,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,987,without Charlson Comorbidity Index (cut off >=2),TwoS
111009872,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,987,without Charlson Comorbidity Index (cut off >=2),TwoS
112009872,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,987,without Charlson Comorbidity Index (cut off >=2),TwoS
113009872,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,987,without Charlson Comorbidity Index (cut off >=2),TwoS
114009872,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,987,without Charlson Comorbidity Index (cut off >=2),TwoS
115009872,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,987,without Charlson Comorbidity Index (cut off >=2),TwoS
116009872,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,987,without Charlson Comorbidity Index (cut off >=2),TwoS
117009872,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,987,without Charlson Comorbidity Index (cut off >=2),TwoS
118009872,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,987,without Charlson Comorbidity Index (cut off >=2),TwoS
101009992,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,999,without Psychological distress,TwoS
102009992,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,999,without Psychological distress,TwoS
103009992,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,999,without Psychological distress,TwoS
104009992,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,999,without Psychological distress,TwoS
105009992,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,999,without Psychological distress,TwoS
106009992,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,999,without Psychological distress,TwoS
107009992,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,999,without Psychological distress,TwoS
108009992,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,999,without Psychological distress,TwoS
109009992,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,999,without Psychological distress,TwoS
110009992,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,999,without Psychological distress,TwoS
111009992,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,999,without Psychological distress,TwoS
112009992,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,999,without Psychological distress,TwoS
113009992,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,999,without Psychological distress,TwoS
114009992,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,999,without Psychological distress,TwoS
115009992,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,999,without Psychological distress,TwoS
116009992,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,999,without Psychological distress,TwoS
117009992,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,999,without Psychological distress,TwoS
118009992,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,999,without Psychological distress,TwoS
101000011,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,1,with Age < 60,TwS
102000011,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,1,with Age < 60,TwS
103000011,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,1,with Age < 60,TwS
104000011,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,1,with Age < 60,TwS
105000011,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,1,with Age < 60,TwS
106000011,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,1,with Age < 60,TwS
107000011,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,1,with Age < 60,TwS
108000011,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,1,with Age < 60,TwS
109000011,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,1,with Age < 60,TwS
110000011,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,1,with Age < 60,TwS
111000011,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,1,with Age < 60,TwS
112000011,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,1,with Age < 60,TwS
113000011,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,1,with Age < 60,TwS
114000011,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,1,with Age < 60,TwS
115000011,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,1,with Age < 60,TwS
116000011,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,1,with Age < 60,TwS
117000011,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,1,with Age < 60,TwS
118000011,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,1,with Age < 60,TwS
101000021,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,2,with Age 60 - 69,TwS
102000021,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,2,with Age 60 - 69,TwS
103000021,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,2,with Age 60 - 69,TwS
104000021,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,2,with Age 60 - 69,TwS
105000021,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,2,with Age 60 - 69,TwS
106000021,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,2,with Age 60 - 69,TwS
107000021,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,2,with Age 60 - 69,TwS
108000021,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,2,with Age 60 - 69,TwS
109000021,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,2,with Age 60 - 69,TwS
110000021,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,2,with Age 60 - 69,TwS
111000021,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,2,with Age 60 - 69,TwS
112000021,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,2,with Age 60 - 69,TwS
113000021,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,2,with Age 60 - 69,TwS
114000021,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,2,with Age 60 - 69,TwS
115000021,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,2,with Age 60 - 69,TwS
116000021,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,2,with Age 60 - 69,TwS
117000021,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,2,with Age 60 - 69,TwS
118000021,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,2,with Age 60 - 69,TwS
101000031,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,3,with Age 70 - 79,TwS
102000031,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,3,with Age 70 - 79,TwS
103000031,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,3,with Age 70 - 79,TwS
104000031,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,3,with Age 70 - 79,TwS
105000031,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,3,with Age 70 - 79,TwS
106000031,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,3,with Age 70 - 79,TwS
107000031,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,3,with Age 70 - 79,TwS
108000031,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,3,with Age 70 - 79,TwS
109000031,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,3,with Age 70 - 79,TwS
110000031,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,3,with Age 70 - 79,TwS
111000031,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,3,with Age 70 - 79,TwS
112000031,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,3,with Age 70 - 79,TwS
113000031,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,3,with Age 70 - 79,TwS
114000031,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,3,with Age 70 - 79,TwS
115000031,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,3,with Age 70 - 79,TwS
116000031,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,3,with Age 70 - 79,TwS
117000031,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,3,with Age 70 - 79,TwS
118000031,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,3,with Age 70 - 79,TwS
101000041,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,4,with Age >= 80,TwS
102000041,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,4,with Age >= 80,TwS
103000041,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,4,with Age >= 80,TwS
104000041,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,4,with Age >= 80,TwS
105000041,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,4,with Age >= 80,TwS
106000041,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,4,with Age >= 80,TwS
107000041,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,4,with Age >= 80,TwS
108000041,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,4,with Age >= 80,TwS
109000041,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,4,with Age >= 80,TwS
110000041,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,4,with Age >= 80,TwS
111000041,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,4,with Age >= 80,TwS
112000041,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,4,with Age >= 80,TwS
113000041,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,4,with Age >= 80,TwS
114000041,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,4,with Age >= 80,TwS
115000041,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,4,with Age >= 80,TwS
116000041,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,4,with Age >= 80,TwS
117000041,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,4,with Age >= 80,TwS
118000041,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,4,with Age >= 80,TwS
101000051,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,5,with Index year = 2016,TwS
102000051,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,5,with Index year = 2016,TwS
103000051,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,5,with Index year = 2016,TwS
104000051,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,5,with Index year = 2016,TwS
105000051,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,5,with Index year = 2016,TwS
106000051,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,5,with Index year = 2016,TwS
107000051,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,5,with Index year = 2016,TwS
108000051,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,5,with Index year = 2016,TwS
109000051,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,5,with Index year = 2016,TwS
110000051,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,5,with Index year = 2016,TwS
111000051,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,5,with Index year = 2016,TwS
112000051,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,5,with Index year = 2016,TwS
113000051,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,5,with Index year = 2016,TwS
114000051,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,5,with Index year = 2016,TwS
115000051,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,5,with Index year = 2016,TwS
116000051,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,5,with Index year = 2016,TwS
117000051,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,5,with Index year = 2016,TwS
118000051,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,5,with Index year = 2016,TwS
101000061,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,6,with Index year = 2017,TwS
102000061,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,6,with Index year = 2017,TwS
103000061,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,6,with Index year = 2017,TwS
104000061,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,6,with Index year = 2017,TwS
105000061,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,6,with Index year = 2017,TwS
106000061,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,6,with Index year = 2017,TwS
107000061,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,6,with Index year = 2017,TwS
108000061,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,6,with Index year = 2017,TwS
109000061,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,6,with Index year = 2017,TwS
110000061,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,6,with Index year = 2017,TwS
111000061,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,6,with Index year = 2017,TwS
112000061,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,6,with Index year = 2017,TwS
113000061,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,6,with Index year = 2017,TwS
114000061,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,6,with Index year = 2017,TwS
115000061,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,6,with Index year = 2017,TwS
116000061,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,6,with Index year = 2017,TwS
117000061,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,6,with Index year = 2017,TwS
118000061,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,6,with Index year = 2017,TwS
101000071,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,7,with Index year = 2018,TwS
102000071,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,7,with Index year = 2018,TwS
103000071,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,7,with Index year = 2018,TwS
104000071,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,7,with Index year = 2018,TwS
105000071,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,7,with Index year = 2018,TwS
106000071,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,7,with Index year = 2018,TwS
107000071,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,7,with Index year = 2018,TwS
108000071,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,7,with Index year = 2018,TwS
109000071,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,7,with Index year = 2018,TwS
110000071,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,7,with Index year = 2018,TwS
111000071,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,7,with Index year = 2018,TwS
112000071,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,7,with Index year = 2018,TwS
113000071,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,7,with Index year = 2018,TwS
114000071,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,7,with Index year = 2018,TwS
115000071,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,7,with Index year = 2018,TwS
116000071,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,7,with Index year = 2018,TwS
117000071,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,7,with Index year = 2018,TwS
118000071,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,7,with Index year = 2018,TwS
101000081,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,8,with Index year = 2019,TwS
102000081,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,8,with Index year = 2019,TwS
103000081,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,8,with Index year = 2019,TwS
104000081,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,8,with Index year = 2019,TwS
105000081,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,8,with Index year = 2019,TwS
106000081,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,8,with Index year = 2019,TwS
107000081,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,8,with Index year = 2019,TwS
108000081,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,8,with Index year = 2019,TwS
109000081,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,8,with Index year = 2019,TwS
110000081,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,8,with Index year = 2019,TwS
111000081,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,8,with Index year = 2019,TwS
112000081,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,8,with Index year = 2019,TwS
113000081,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,8,with Index year = 2019,TwS
114000081,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,8,with Index year = 2019,TwS
115000081,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,8,with Index year = 2019,TwS
116000081,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,8,with Index year = 2019,TwS
117000081,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,8,with Index year = 2019,TwS
118000081,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,8,with Index year = 2019,TwS
101000091,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,9,with Index year = 2020,TwS
102000091,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,9,with Index year = 2020,TwS
103000091,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,9,with Index year = 2020,TwS
104000091,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,9,with Index year = 2020,TwS
105000091,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,9,with Index year = 2020,TwS
106000091,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,9,with Index year = 2020,TwS
107000091,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,9,with Index year = 2020,TwS
108000091,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,9,with Index year = 2020,TwS
109000091,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,9,with Index year = 2020,TwS
110000091,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,9,with Index year = 2020,TwS
111000091,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,9,with Index year = 2020,TwS
112000091,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,9,with Index year = 2020,TwS
113000091,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,9,with Index year = 2020,TwS
114000091,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,9,with Index year = 2020,TwS
115000091,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,9,with Index year = 2020,TwS
116000091,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,9,with Index year = 2020,TwS
117000091,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,9,with Index year = 2020,TwS
118000091,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,9,with Index year = 2020,TwS
101002831,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,283,with Performance Status ECOG=0,TwS
102002831,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,283,with Performance Status ECOG=0,TwS
103002831,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,283,with Performance Status ECOG=0,TwS
104002831,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,283,with Performance Status ECOG=0,TwS
105002831,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,283,with Performance Status ECOG=0,TwS
106002831,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,283,with Performance Status ECOG=0,TwS
107002831,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,283,with Performance Status ECOG=0,TwS
108002831,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,283,with Performance Status ECOG=0,TwS
109002831,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,283,with Performance Status ECOG=0,TwS
110002831,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,283,with Performance Status ECOG=0,TwS
111002831,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,283,with Performance Status ECOG=0,TwS
112002831,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,283,with Performance Status ECOG=0,TwS
113002831,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,283,with Performance Status ECOG=0,TwS
114002831,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,283,with Performance Status ECOG=0,TwS
115002831,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,283,with Performance Status ECOG=0,TwS
116002831,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,283,with Performance Status ECOG=0,TwS
117002831,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,283,with Performance Status ECOG=0,TwS
118002831,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,283,with Performance Status ECOG=0,TwS
101002841,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,284,with Hypertension,TwS
102002841,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,284,with Hypertension,TwS
103002841,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,284,with Hypertension,TwS
104002841,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,284,with Hypertension,TwS
105002841,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,284,with Hypertension,TwS
106002841,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,284,with Hypertension,TwS
107002841,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,284,with Hypertension,TwS
108002841,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,284,with Hypertension,TwS
109002841,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,284,with Hypertension,TwS
110002841,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,284,with Hypertension,TwS
111002841,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,284,with Hypertension,TwS
112002841,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,284,with Hypertension,TwS
113002841,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,284,with Hypertension,TwS
114002841,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,284,with Hypertension,TwS
115002841,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,284,with Hypertension,TwS
116002841,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,284,with Hypertension,TwS
117002841,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,284,with Hypertension,TwS
118002841,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,284,with Hypertension,TwS
101002861,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,286,with Cardiovascular Disease Event,TwS
102002861,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,286,with Cardiovascular Disease Event,TwS
103002861,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,286,with Cardiovascular Disease Event,TwS
104002861,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,286,with Cardiovascular Disease Event,TwS
105002861,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,286,with Cardiovascular Disease Event,TwS
106002861,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,286,with Cardiovascular Disease Event,TwS
107002861,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,286,with Cardiovascular Disease Event,TwS
108002861,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,286,with Cardiovascular Disease Event,TwS
109002861,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,286,with Cardiovascular Disease Event,TwS
110002861,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,286,with Cardiovascular Disease Event,TwS
111002861,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,286,with Cardiovascular Disease Event,TwS
112002861,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,286,with Cardiovascular Disease Event,TwS
113002861,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,286,with Cardiovascular Disease Event,TwS
114002861,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,286,with Cardiovascular Disease Event,TwS
115002861,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,286,with Cardiovascular Disease Event,TwS
116002861,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,286,with Cardiovascular Disease Event,TwS
117002861,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,286,with Cardiovascular Disease Event,TwS
118002861,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,286,with Cardiovascular Disease Event,TwS
101002871,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,287,with Diabetes 2,TwS
102002871,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,287,with Diabetes 2,TwS
103002871,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,287,with Diabetes 2,TwS
104002871,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,287,with Diabetes 2,TwS
105002871,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,287,with Diabetes 2,TwS
106002871,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,287,with Diabetes 2,TwS
107002871,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,287,with Diabetes 2,TwS
108002871,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,287,with Diabetes 2,TwS
109002871,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,287,with Diabetes 2,TwS
110002871,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,287,with Diabetes 2,TwS
111002871,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,287,with Diabetes 2,TwS
112002871,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,287,with Diabetes 2,TwS
113002871,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,287,with Diabetes 2,TwS
114002871,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,287,with Diabetes 2,TwS
115002871,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,287,with Diabetes 2,TwS
116002871,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,287,with Diabetes 2,TwS
117002871,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,287,with Diabetes 2,TwS
118002871,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,287,with Diabetes 2,TwS
101002881,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,288,with Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwS
102002881,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,288,with Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwS
103002881,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,288,with Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwS
104002881,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,288,with Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwS
105002881,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,288,with Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwS
106002881,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,288,with Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwS
107002881,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,288,with Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwS
108002881,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,288,with Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwS
109002881,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,288,with Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwS
110002881,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,288,with Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwS
111002881,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,288,with Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwS
112002881,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,288,with Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwS
113002881,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,288,with Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwS
114002881,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,288,with Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwS
115002881,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,288,with Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwS
116002881,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,288,with Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwS
117002881,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,288,with Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwS
118002881,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,288,with Venous thromboembolic (pulmonary embolism and deep vein thrombosis),TwS
101002891,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,289,with Anxiety,TwS
102002891,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,289,with Anxiety,TwS
103002891,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,289,with Anxiety,TwS
104002891,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,289,with Anxiety,TwS
105002891,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,289,with Anxiety,TwS
106002891,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,289,with Anxiety,TwS
107002891,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,289,with Anxiety,TwS
108002891,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,289,with Anxiety,TwS
109002891,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,289,with Anxiety,TwS
110002891,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,289,with Anxiety,TwS
111002891,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,289,with Anxiety,TwS
112002891,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,289,with Anxiety,TwS
113002891,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,289,with Anxiety,TwS
114002891,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,289,with Anxiety,TwS
115002891,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,289,with Anxiety,TwS
116002891,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,289,with Anxiety,TwS
117002891,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,289,with Anxiety,TwS
118002891,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,289,with Anxiety,TwS
101003101,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,310,with Fatique or malaise,TwS
102003101,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,310,with Fatique or malaise,TwS
103003101,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,310,with Fatique or malaise,TwS
104003101,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,310,with Fatique or malaise,TwS
105003101,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,310,with Fatique or malaise,TwS
106003101,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,310,with Fatique or malaise,TwS
107003101,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,310,with Fatique or malaise,TwS
108003101,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,310,with Fatique or malaise,TwS
109003101,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,310,with Fatique or malaise,TwS
110003101,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,310,with Fatique or malaise,TwS
111003101,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,310,with Fatique or malaise,TwS
112003101,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,310,with Fatique or malaise,TwS
113003101,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,310,with Fatique or malaise,TwS
114003101,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,310,with Fatique or malaise,TwS
115003101,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,310,with Fatique or malaise,TwS
116003101,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,310,with Fatique or malaise,TwS
117003101,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,310,with Fatique or malaise,TwS
118003101,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,310,with Fatique or malaise,TwS
101004031,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,403,with Osteopenia and Osteoporosis,TwS
102004031,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,403,with Osteopenia and Osteoporosis,TwS
103004031,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,403,with Osteopenia and Osteoporosis,TwS
104004031,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,403,with Osteopenia and Osteoporosis,TwS
105004031,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,403,with Osteopenia and Osteoporosis,TwS
106004031,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,403,with Osteopenia and Osteoporosis,TwS
107004031,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,403,with Osteopenia and Osteoporosis,TwS
108004031,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,403,with Osteopenia and Osteoporosis,TwS
109004031,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,403,with Osteopenia and Osteoporosis,TwS
110004031,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,403,with Osteopenia and Osteoporosis,TwS
111004031,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,403,with Osteopenia and Osteoporosis,TwS
112004031,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,403,with Osteopenia and Osteoporosis,TwS
113004031,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,403,with Osteopenia and Osteoporosis,TwS
114004031,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,403,with Osteopenia and Osteoporosis,TwS
115004031,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,403,with Osteopenia and Osteoporosis,TwS
116004031,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,403,with Osteopenia and Osteoporosis,TwS
117004031,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,403,with Osteopenia and Osteoporosis,TwS
118004031,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,403,with Osteopenia and Osteoporosis,TwS
101004071,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,407,with Anemia,TwS
102004071,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,407,with Anemia,TwS
103004071,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,407,with Anemia,TwS
104004071,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,407,with Anemia,TwS
105004071,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,407,with Anemia,TwS
106004071,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,407,with Anemia,TwS
107004071,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,407,with Anemia,TwS
108004071,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,407,with Anemia,TwS
109004071,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,407,with Anemia,TwS
110004071,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,407,with Anemia,TwS
111004071,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,407,with Anemia,TwS
112004071,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,407,with Anemia,TwS
113004071,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,407,with Anemia,TwS
114004071,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,407,with Anemia,TwS
115004071,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,407,with Anemia,TwS
116004071,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,407,with Anemia,TwS
117004071,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,407,with Anemia,TwS
118004071,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,407,with Anemia,TwS
101004221,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,422,with Performance Status ECOG=1,TwS
102004221,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,422,with Performance Status ECOG=1,TwS
103004221,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,422,with Performance Status ECOG=1,TwS
104004221,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,422,with Performance Status ECOG=1,TwS
105004221,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,422,with Performance Status ECOG=1,TwS
106004221,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,422,with Performance Status ECOG=1,TwS
107004221,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,422,with Performance Status ECOG=1,TwS
108004221,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,422,with Performance Status ECOG=1,TwS
109004221,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,422,with Performance Status ECOG=1,TwS
110004221,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,422,with Performance Status ECOG=1,TwS
111004221,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,422,with Performance Status ECOG=1,TwS
112004221,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,422,with Performance Status ECOG=1,TwS
113004221,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,422,with Performance Status ECOG=1,TwS
114004221,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,422,with Performance Status ECOG=1,TwS
115004221,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,422,with Performance Status ECOG=1,TwS
116004221,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,422,with Performance Status ECOG=1,TwS
117004221,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,422,with Performance Status ECOG=1,TwS
118004221,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,422,with Performance Status ECOG=1,TwS
101007971,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,797,with Hepatotoxicity/Liver failure,TwS
102007971,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,797,with Hepatotoxicity/Liver failure,TwS
103007971,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,797,with Hepatotoxicity/Liver failure,TwS
104007971,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,797,with Hepatotoxicity/Liver failure,TwS
105007971,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,797,with Hepatotoxicity/Liver failure,TwS
106007971,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,797,with Hepatotoxicity/Liver failure,TwS
107007971,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,797,with Hepatotoxicity/Liver failure,TwS
108007971,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,797,with Hepatotoxicity/Liver failure,TwS
109007971,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,797,with Hepatotoxicity/Liver failure,TwS
110007971,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,797,with Hepatotoxicity/Liver failure,TwS
111007971,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,797,with Hepatotoxicity/Liver failure,TwS
112007971,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,797,with Hepatotoxicity/Liver failure,TwS
113007971,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,797,with Hepatotoxicity/Liver failure,TwS
114007971,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,797,with Hepatotoxicity/Liver failure,TwS
115007971,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,797,with Hepatotoxicity/Liver failure,TwS
116007971,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,797,with Hepatotoxicity/Liver failure,TwS
117007971,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,797,with Hepatotoxicity/Liver failure,TwS
118007971,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,797,with Hepatotoxicity/Liver failure,TwS
101008081,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,808,with Dementia,TwS
102008081,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,808,with Dementia,TwS
103008081,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,808,with Dementia,TwS
104008081,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,808,with Dementia,TwS
105008081,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,808,with Dementia,TwS
106008081,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,808,with Dementia,TwS
107008081,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,808,with Dementia,TwS
108008081,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,808,with Dementia,TwS
109008081,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,808,with Dementia,TwS
110008081,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,808,with Dementia,TwS
111008081,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,808,with Dementia,TwS
112008081,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,808,with Dementia,TwS
113008081,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,808,with Dementia,TwS
114008081,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,808,with Dementia,TwS
115008081,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,808,with Dementia,TwS
116008081,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,808,with Dementia,TwS
117008081,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,808,with Dementia,TwS
118008081,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,808,with Dementia,TwS
101008101,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,810,with Memory impairment,TwS
102008101,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,810,with Memory impairment,TwS
103008101,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,810,with Memory impairment,TwS
104008101,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,810,with Memory impairment,TwS
105008101,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,810,with Memory impairment,TwS
106008101,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,810,with Memory impairment,TwS
107008101,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,810,with Memory impairment,TwS
108008101,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,810,with Memory impairment,TwS
109008101,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,810,with Memory impairment,TwS
110008101,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,810,with Memory impairment,TwS
111008101,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,810,with Memory impairment,TwS
112008101,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,810,with Memory impairment,TwS
113008101,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,810,with Memory impairment,TwS
114008101,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,810,with Memory impairment,TwS
115008101,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,810,with Memory impairment,TwS
116008101,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,810,with Memory impairment,TwS
117008101,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,810,with Memory impairment,TwS
118008101,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,810,with Memory impairment,TwS
101008421,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,842,with Depression,TwS
102008421,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,842,with Depression,TwS
103008421,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,842,with Depression,TwS
104008421,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,842,with Depression,TwS
105008421,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,842,with Depression,TwS
106008421,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,842,with Depression,TwS
107008421,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,842,with Depression,TwS
108008421,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,842,with Depression,TwS
109008421,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,842,with Depression,TwS
110008421,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,842,with Depression,TwS
111008421,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,842,with Depression,TwS
112008421,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,842,with Depression,TwS
113008421,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,842,with Depression,TwS
114008421,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,842,with Depression,TwS
115008421,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,842,with Depression,TwS
116008421,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,842,with Depression,TwS
117008421,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,842,with Depression,TwS
118008421,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,842,with Depression,TwS
101008511,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,851,with Respiratory distress,TwS
102008511,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,851,with Respiratory distress,TwS
103008511,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,851,with Respiratory distress,TwS
104008511,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,851,with Respiratory distress,TwS
105008511,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,851,with Respiratory distress,TwS
106008511,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,851,with Respiratory distress,TwS
107008511,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,851,with Respiratory distress,TwS
108008511,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,851,with Respiratory distress,TwS
109008511,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,851,with Respiratory distress,TwS
110008511,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,851,with Respiratory distress,TwS
111008511,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,851,with Respiratory distress,TwS
112008511,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,851,with Respiratory distress,TwS
113008511,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,851,with Respiratory distress,TwS
114008511,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,851,with Respiratory distress,TwS
115008511,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,851,with Respiratory distress,TwS
116008511,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,851,with Respiratory distress,TwS
117008511,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,851,with Respiratory distress,TwS
118008511,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,851,with Respiratory distress,TwS
101008891,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,889,with Kidney failure,TwS
102008891,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,889,with Kidney failure,TwS
103008891,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,889,with Kidney failure,TwS
104008891,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,889,with Kidney failure,TwS
105008891,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,889,with Kidney failure,TwS
106008891,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,889,with Kidney failure,TwS
107008891,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,889,with Kidney failure,TwS
108008891,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,889,with Kidney failure,TwS
109008891,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,889,with Kidney failure,TwS
110008891,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,889,with Kidney failure,TwS
111008891,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,889,with Kidney failure,TwS
112008891,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,889,with Kidney failure,TwS
113008891,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,889,with Kidney failure,TwS
114008891,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,889,with Kidney failure,TwS
115008891,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,889,with Kidney failure,TwS
116008891,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,889,with Kidney failure,TwS
117008891,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,889,with Kidney failure,TwS
118008891,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,889,with Kidney failure,TwS
101009841,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,984,with BMI above 30,TwS
102009841,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,984,with BMI above 30,TwS
103009841,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,984,with BMI above 30,TwS
104009841,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,984,with BMI above 30,TwS
105009841,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,984,with BMI above 30,TwS
106009841,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,984,with BMI above 30,TwS
107009841,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,984,with BMI above 30,TwS
108009841,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,984,with BMI above 30,TwS
109009841,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,984,with BMI above 30,TwS
110009841,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,984,with BMI above 30,TwS
111009841,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,984,with BMI above 30,TwS
112009841,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,984,with BMI above 30,TwS
113009841,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,984,with BMI above 30,TwS
114009841,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,984,with BMI above 30,TwS
115009841,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,984,with BMI above 30,TwS
116009841,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,984,with BMI above 30,TwS
117009841,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,984,with BMI above 30,TwS
118009841,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,984,with BMI above 30,TwS
101009851,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,985,with Charlson Comorbidity Index (cut off 0),TwS
102009851,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,985,with Charlson Comorbidity Index (cut off 0),TwS
103009851,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,985,with Charlson Comorbidity Index (cut off 0),TwS
104009851,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,985,with Charlson Comorbidity Index (cut off 0),TwS
105009851,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,985,with Charlson Comorbidity Index (cut off 0),TwS
106009851,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,985,with Charlson Comorbidity Index (cut off 0),TwS
107009851,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,985,with Charlson Comorbidity Index (cut off 0),TwS
108009851,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,985,with Charlson Comorbidity Index (cut off 0),TwS
109009851,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,985,with Charlson Comorbidity Index (cut off 0),TwS
110009851,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,985,with Charlson Comorbidity Index (cut off 0),TwS
111009851,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,985,with Charlson Comorbidity Index (cut off 0),TwS
112009851,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,985,with Charlson Comorbidity Index (cut off 0),TwS
113009851,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,985,with Charlson Comorbidity Index (cut off 0),TwS
114009851,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,985,with Charlson Comorbidity Index (cut off 0),TwS
115009851,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,985,with Charlson Comorbidity Index (cut off 0),TwS
116009851,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,985,with Charlson Comorbidity Index (cut off 0),TwS
117009851,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,985,with Charlson Comorbidity Index (cut off 0),TwS
118009851,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,985,with Charlson Comorbidity Index (cut off 0),TwS
101009861,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,986,with Charlson Comorbidity Index (cut off 1),TwS
102009861,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,986,with Charlson Comorbidity Index (cut off 1),TwS
103009861,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,986,with Charlson Comorbidity Index (cut off 1),TwS
104009861,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,986,with Charlson Comorbidity Index (cut off 1),TwS
105009861,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,986,with Charlson Comorbidity Index (cut off 1),TwS
106009861,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,986,with Charlson Comorbidity Index (cut off 1),TwS
107009861,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,986,with Charlson Comorbidity Index (cut off 1),TwS
108009861,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,986,with Charlson Comorbidity Index (cut off 1),TwS
109009861,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,986,with Charlson Comorbidity Index (cut off 1),TwS
110009861,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,986,with Charlson Comorbidity Index (cut off 1),TwS
111009861,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,986,with Charlson Comorbidity Index (cut off 1),TwS
112009861,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,986,with Charlson Comorbidity Index (cut off 1),TwS
113009861,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,986,with Charlson Comorbidity Index (cut off 1),TwS
114009861,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,986,with Charlson Comorbidity Index (cut off 1),TwS
115009861,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,986,with Charlson Comorbidity Index (cut off 1),TwS
116009861,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,986,with Charlson Comorbidity Index (cut off 1),TwS
117009861,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,986,with Charlson Comorbidity Index (cut off 1),TwS
118009861,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,986,with Charlson Comorbidity Index (cut off 1),TwS
101009871,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,987,with Charlson Comorbidity Index (cut off >=2),TwS
102009871,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,987,with Charlson Comorbidity Index (cut off >=2),TwS
103009871,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,987,with Charlson Comorbidity Index (cut off >=2),TwS
104009871,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,987,with Charlson Comorbidity Index (cut off >=2),TwS
105009871,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,987,with Charlson Comorbidity Index (cut off >=2),TwS
106009871,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,987,with Charlson Comorbidity Index (cut off >=2),TwS
107009871,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,987,with Charlson Comorbidity Index (cut off >=2),TwS
108009871,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,987,with Charlson Comorbidity Index (cut off >=2),TwS
109009871,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,987,with Charlson Comorbidity Index (cut off >=2),TwS
110009871,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,987,with Charlson Comorbidity Index (cut off >=2),TwS
111009871,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,987,with Charlson Comorbidity Index (cut off >=2),TwS
112009871,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,987,with Charlson Comorbidity Index (cut off >=2),TwS
113009871,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,987,with Charlson Comorbidity Index (cut off >=2),TwS
114009871,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,987,with Charlson Comorbidity Index (cut off >=2),TwS
115009871,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,987,with Charlson Comorbidity Index (cut off >=2),TwS
116009871,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,987,with Charlson Comorbidity Index (cut off >=2),TwS
117009871,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,987,with Charlson Comorbidity Index (cut off >=2),TwS
118009871,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,987,with Charlson Comorbidity Index (cut off >=2),TwS
101009991,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,999,with Psychological distress,TwS
102009991,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,999,with Psychological distress,TwS
103009991,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,999,with Psychological distress,TwS
104009991,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,999,with Psychological distress,TwS
105009991,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,999,with Psychological distress,TwS
106009991,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,999,with Psychological distress,TwS
107009991,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,999,with Psychological distress,TwS
108009991,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,999,with Psychological distress,TwS
109009991,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,999,with Psychological distress,TwS
110009991,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,999,with Psychological distress,TwS
111009991,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,999,with Psychological distress,TwS
112009991,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,999,with Psychological distress,TwS
113009991,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,999,with Psychological distress,TwS
114009991,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,999,with Psychological distress,TwS
115009991,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,999,with Psychological distress,TwS
116009991,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,999,with Psychological distress,TwS
117009991,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,999,with Psychological distress,TwS
118009991,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,999,with Psychological distress,TwS
